Related Experiment Video
Updated: Feb 14, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.3K
Intracavitary Therapeutics for Pleural Malignancies.
Vivek Murthy1, Keshav Mangalick1, Daniel H Sterman1
1NYU PORT (Pulmonary Oncology Research Team), Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, NYU Langone Health, 550 First Avenue Suite 5D, New York, NY 10016, USA.
Clinics in Chest Medicine
|February 14, 2018
Summary
Pleural malignancies are difficult to treat but occur in an accessible space. Intracavitary delivery of novel therapeutics offers a promising approach to target cancer directly and reduce side effects.
Area of Science:
- Oncology
- Thoracic Surgery
Background:
- Pleural malignancies present significant therapeutic challenges.
- These cancers are often resistant to conventional treatments.
- The pleural space offers unique advantages for localized treatment delivery and monitoring.
Purpose of the Study:
- To explore the rationale for intracavitary delivery of novel therapeutics for pleural malignancies.
- To highlight the benefits of targeting the pleural space for enhanced efficacy and reduced systemic toxicity.
Main Methods:
- Review of existing literature on pleural space accessibility and therapeutic delivery.
- Analysis of the potential for serial sampling to assess treatment response and toxicity.
Main Results:
- The pleural space is readily accessible for examination, biopsy, and serial sampling.
- Intracavitary drug administration can maximize efficacy at the tumor site.
- Localized delivery may mitigate systemic adverse effects associated with conventional therapies.
Conclusions:
- The unique accessibility of the pleural space supports the direct administration of novel therapeutics.
- Intracavitary delivery represents a promising strategy for managing pleural malignancies.
- Targeted delivery enhances treatment efficacy and patient safety.
Related Concept Videos
01:25Pleural Effusion I: Introduction
4.5K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.5K
01:30Pleural Disorders: Types and Brief Description
723
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
723
01:28Pleural Effusion II: Symptoms and Management
825
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
825
01:13Therapeutic Index
7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
01:30Therapeutic Communication
8.8K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.8K
01:26Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K